LIPA1 - Overview: Lipoprotein(a), Serum
Cardiovascular disease (CVD) risk refinement in patients with moderate or high risk based on conventional risk factors or patients with clinical suspicion of residual CV risk not identified by other lipid parameters
LECT2 - Overview: Leukocyte Cell-Derived Chemotaxin 2 (LECT2), Immunostains Without Interpretation
Identification and classification of amyloid subtypes in tissue
IRF8 - Overview: Interferon Regulatory Factor 8 (IRF8) Immunostain, Technical Component Only
Identification of monoblasts in acute monoblastic/monocytic leukemia and chronic myelomonocytic leukemia
NF4FS - Overview: Neurofascin-155 IgG4, Flow Cytometry, Serum
Evaluating patients with an underlying demyelinating neuropathy Diagnosis of a neurofascin-155 IgG4 mediated neuropathy
TOBRA - Overview: Tobramycin, Random, Serum
Monitoring adequacy of serum concentration during tobramycin therapy This unit code is used whenever a specimen is submitted or collected without collection timing information. The phlebotomist should use this unit code if she or he does...
VLTB - Overview: Volatile Screen, Blood
Detection and quantitation of acetone, methanol, isopropanol, and ethanol in whole blood Quantification of the concentration of ethanol in blood that correlates with the degree of intoxication Evaluation of toxicity to the measured...
PNPAB - Overview: Paraneoplastic Pemphigus Antibody, IgG, Serum
Diagnosis of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome in the setting of erosive or lichenoid mucocutaneous disease
FAS1A - Overview: Anti-SAE1 Ab, IgG
Anti-SAE1 Ab, IgG
FMARI - Overview: Cannabinoid Analysis, Whole Blood
Cannabinoid Analysis, Whole Blood
Mayo Clinic Ranked No. 1 Hospital Nationwide by U.S. News & World Report - Insights
Report’s 29th annual "Best Hospitals Honor Roll" published online on August 14. Mayo Clinic also ranked No. 1 in more specialties than any other hospital in the country....
NELL-1 [Test in Focus] - Insights
D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic...
Looking Back on Clinical Chemistry 1 - Insights
in the Mayo Clinic Medical Laboratory Science program, takes a look back on her Clinical Chemistry 1 course....
Detection of (1→3)-𝝱-D-glucan as a Marker of Invasive Fungal Disease - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss the detection of (1→3)-β-D-glucan (BDG) in serum as a biomarker for the presence of invasive fungal infections....
Orexin-A/Hypocretin-1 for the Diagnosis of Type 1 Narcolepsy [Test in Focus] - Insights
test to perform as well as to interpret. The orexin-A/hypocretin-1 test is a sensitive and specific alternative to the MSLT to diagnose type 1 narcolepsy....